EcoDrugPlus


Keyword(s):	Human Metabolites
Molecule Category	Free-form

Keyword(s):

Human Metabolites

Molecule Category

Free-form


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70


InChI Key	SEFQOXAMNBWQDZ-JYFOCSDGSA-N
Smiles	O(CC=CC=1C=CC=CC1)C(OCC=CC=2C=CC=CC2)C(=C)C=3C=CC=CC3
InChI	InChI=1/C27H26O2/c1-23(26-19-9-4-10-20-26)27(28-21-11-17-24-13-5-2-6-14-24)29-22-12-18-25-15-7-3-8-16-25/h2-20,27H,1,21-22H2

InChI Key

SEFQOXAMNBWQDZ-JYFOCSDGSA-N

Smiles

O(CC=CC=1C=CC=CC1)C(OCC=CC=2C=CC=CC2)C(=C)C=3C=CC=CC3

InChI

InChI=1/C27H26O2/c1-23(26-19-9-4-10-20-26)27(28-21-11-17-24-13-5-2-6-14-24)29-22-12-18-25-15-7-3-8-16-25/h2-20,27H,1,21-22H2

Property Name	Value
Molecular Formula	C27H26O2
Molecular Weight	382.19
AlogP	6.49
Hydrogen Bond Acceptor	2.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	10.0
Polar Surface Area	18.46
Molecular species	None
Aromatic Rings	3.0
Heavy Atoms	29.0

Property Name

Value

Molecular Formula

C27H26O2

Molecular Weight

382.19

AlogP

6.49

Hydrogen Bond Acceptor

2.0

Hydrogen Bond Donor

0.0

Number of Rotational Bond

10.0

Polar Surface Area

18.46

Molecular species

None

Aromatic Rings

3.0

Heavy Atoms

29.0

Resources	Reference
CAS NUMBER	60487-81-2
NORMAN SUSDAT
PubChem	21118401

Resources

Reference

CAS NUMBER

60487-81-2

NORMAN SUSDAT

PubChem

21118401


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

[BIS[(3-PHENYLALLYL)OXY]METHYL]VINYLBENZENE

Structure

Physicochemical Descriptors

Cross References